Wood disks in various states of decay can be inexpensively preserved and prepared for accurate crossdating and precise tree-ring measurement by impregnation with commercial wood glue. The technique does not affect the dimensions or physiological features of samples preserved in this manner. Dead red spruce trees on Mt. Washington, New Hampshire, remain available for dendrochronological examination as long as 29 years after their last year of stem growth.

This work has explored the capability of a mixed film composed of oligonucleotides and oligomers to improve the selectivity for the detection of fully complementary oligonucleotide targets in comparison to partially complementary targets which have one and three base-pair mismatched sites. The intention was to introduce a “matrix isolation” effect on oligonucleotide probe molecules by surrounding the probes with oligomers, thereby reducing oligonucleotide-to-oligonucleotide and/or oligonucleotide-to-surface interactions. This resulted in a more homogeneous environment for probes, thereby minimizing the dispersity of energetics associated with formation of double-stranded hybrids. The mixed film was constructed by immobilizing pre-synthesized oligonucleotides onto a mixed aminosilane layer and then growing the oligomer portion by surface-initiated atom transfer radical polymerization (ATRP) of 2-hydroxy methacrylate (PHEMA). The performance of the mixed film was compared to films composed of only oligonucleotides in a series of hybridization and melt curve experiments. Surface characterization techniques were used to confirm the growth of the oligomer portion as well as the presence of both oligonucleotides and oligomer components. Polyatomic bismuth cluster ions as sources for time-of-flight secondary ion mass spectrometry experiments could detect both components of the mixed film at a high sensitivity even though the oligomer portion was at least 200-fold in excess. At the various ionic strengths investigated, the mixed films were found to increase the selectivity for fully complementary targets over mismatched targets by increasing the sharpness of melt curves and melting temperature differences (delta Tm) by 2- to 3-fold, and by reducing non-specific adsorption. This resulted in improved resolution between the melt curves of fully and partially complementary targets. A fluorescence lifetime investigation of the Cy3 emission demonstrated that Cy3-labeled oligonucleotide probes experienced a more rigid microenvironment in the mixed films. These experiments demonstrated that a mixed film composed of oligonucleotides and PHEMA can be prepared on silica-based substrates, and that they can improve the selectivity for SNP discrimination compared to conventional oligonucleotide films.

Cell adhesion is the first step of cell response to materials and the extracellular matrix (ECM), and is essential to all cell behaviours such as cell proliferation, differentiation, migration and apoptosis for anchor-dependent cells. Therefore, studies of cell attachment have important implications to control and study cell behaviours. During many developed techniques for cell attachment, the manipulation of surface chemistry is a very important method to control initial cell attachment. To control cell adhesion on a two-dimensional surface is a simple model to study cell behaviours, and is a fundamental topic for cell biology, tissue engineering, and the development of biosensors. From the engineering point of view, the preparation of a material with controllable surface chemistry can help studies of cell behaviours and help scientists understand how surface features and chemistry influence cell behaviours. During the fabrication, the challenge is to create a surface with heterogeneous surface properties in the micro scale and subsequently to guide cell initial adhesion. In order to control cell adhesion in a spatial and temporal manner, a photochemical method to control surface chemistry was employed to control the surface property for cell adhesion in this project. Two photocleavable derivatives of the nitrobenzyl group were tried on two types of surfaces: a model self-assembled monolayer (SAM) with alkanethiol-gold surface and biodegradable chitosan. Reactive functional groups on two different surfaces can be inactivated by covalent binding with these photocleavable molecules, and light can be further introduced into the system as a stimulus to recover their reactivity. By simply applying a photomask with diffe

Poly Brominated Diphenyl Ethers (PBDEs) are known flame retardants with highly persistent and lipophilic in nature. The continued usage of PBDE in various products amplifies the human burden of PBDEs. It is therefore, important to study the potential toxicological and/or biological effects of PBDE exposure in human. In this study we investigated the mode of action of PBDE induced toxicity in human liver by exposing human hepatocarcinoma cells in a time (24-72h) and dose (0-100μM) dependent manner. The highest test dose caused an inhibition in cell viability up to 50% after 72h, whereas lower doses (<50μM) showed slight increase in cell viability. Likewise, higher doses caused significant accumulation of intracellular ROS over time. Further, increase in caspase-3 enzyme levels and DNA fragmentation showed that, lower brominated PBDEs induce liver toxicity through accumulation of toxic metabolites and reactive oxygen species over time leading to caspase-mediated apoptotic cell death.

Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal.

Dans cette étude, des copolymères à blocs rigide-flexible comprenant des segments donneur [poly(3-hexylthiophène) régiorégulier, (rr-P3HT)] et accepteurs d’électrons (C60) ont été synthétisés. L’auto-assemblage en masse de ces copolymères à blocs avait pour objectif d’atteindre des morphologies dont la taille des domaines coïncide avec la distance idéale de transport de l’exciton (~10 nm) en vue d’utiliser ces systèmes comme matériaux de couche active dans les cellules photovoltaïques organiques de type P3HT-PCBM.La maîtrise et l'optimisation des conditions de synthèse de rr-P3HT de fonctionnalité terminale bien définie nous ont permis d'accéder à différentes architectures de copolymères linéaires di- et triblocs, constitués de P3HT comme bloc rigide et de polystyrène ou poly(4-vinylpyridine) comme bloc ‘flexible’. La fonctionnalisation du bloc flexible avec des dérivés du fullerène (C60 ou PCBM) a ensuite été réalisée et ces copolymères utilisés comme additifs pour stabiliser la morphologie de la couche active des cellules solaires organiques de type P3HT/PCBM. Les caractéristiques photovoltaïques des matériaux ainsi préparés ont été déterminées et corrélées aux analyses morphologiques de la couche active. / The performance of organic photovoltaic cells mainly depends on the active layer nano-morphology. Rod-coil block copolymers (BCPs) are well known in their ability to self-assemble into well-ordered nanoscopic morphologies. BCPs containing electron-donor and acceptor segments are of particular interest for use in photovoltaic cells because electronic light-excited states exist over distances similar to the typical size of block copolymer domains (~10 nm). Therefore, we designed novel donor-acceptor BCPs to exploit this coincidence in dimensions. This thesis is focused on BCPs based on regioregular poly(3-hexylthiophene) (rr-P3HT) due to its high hole mobility and good processibility from various solvents. Simplified and versatile syntheses of donor-acceptor rod-coil di- and tri- BCPs consisting of the donor block P3HT (rod) and polystyrene or poly(4-vinylpyridine) (coil) blocks to carry the acceptor C60 in different ways were developed. These materials were used as surfactants to stabilize the nano-morphology of reference P3HT: [6,6]-phenyl-C61-butyric acid methyl ester (PCBM) based devices. Photovoltaic characterizations were then tied to copolymer structural data with the help of AFM and a range of complementary characterization techniques.

Conductive polymers, since from their discovery, have become a prominent area of research and found many useful applications in all fields of our daily life. Examples are light emitting diodes, heat generation, chemical sensors and electro-active membranes. Polymer coated textile substrates give flexible and lightweight materials. One well utilized and thoroughly explored conductive polymer is poly(3,4-ethylenedioxythiophene) also known as PEDOT. Although there are different ways to produce PEDOT one of the most common is the VPP technique. The typical procedure when using VPP is to introduce the monomer vapor to an oxidant coated substrate so that it polymerizes on the surface of the substrate. Throughout this study, the VPP technique has been used to produce PEDOT on different textile fibers. Aim was first of all optimizing the process gaining low electric resistance, i. e. high conductivity, of produced coated fibers but also multilayer coatings of fibers. Outcome indicates some parameters not having a clear influence over the results while others had a more distinct impact. A noteworthy result was obtained by coating a substrate, namely lyocell fiber, multiple times with layers deposited directly on each other. This decreased the resistance from 5.1 (± 1.6) kΩ/10 cm to 1.0 (± 0.1) kΩ/10 cm, for one layer and multiple layers respectively. Adding 15 wt. % of the copolymer PEG-PPG-PEG to the oxidant solution decreased the resistance from 6.8 (± 1.2) kΩ/10 cm to 3.9 (± 0.8) kΩ/10 cm. Final conclusion is that among the ways, to improve conductivity for PEDOT coated fibers, applied in this study are best results obtained by multi-layer coating.

Plusieurs agents anticancéreux très puissants sont caractérisés par une solubilité aqueuse limitée et une toxicité systémique importante. Cette dernière serait liée d’une part à la solubilisation des agents anticancéreux à l’aide de surfactifs de bas poids moléculaire, connus pour leur toxicité intrinsèque, et d’autre part, par le manque de spécificité tissulaire des anticancéreux. Les vecteurs colloïdaux à base de polymères permettraient de résoudre certains défis liés à la formulation d’agents anticancéreux hydrophobes. D’abord, les polymères peuvent être sélectionnés afin de répondre à des critères précis de compatibilité, de dégradation et d’affinité pour le médicament à formuler. Ensuite, le fait d’encapsuler l’agent anticancéreux dans un vecteur peut améliorer son efficacité thérapeutique en favorisant son accumulation au niveau du tissu cible, i.e. la tumeur, et ainsi limiter sa distribution au niveau des tissus sains. Des travaux antérieurs menés au sein de notre laboratoire ont mené à la mise au point de micelles à base de poly(N-vinyl-pyrrolidone)-bloc-poly(D,L-lactide) (PVP-b-PDLLA) capables de solubiliser des agents anticancéreux faiblement hydrosolubles dont le PTX. Ce dernier est commercialisé sous le nom de Taxol® et formulé à l’aide du Crémophor EL (CrEL), un surfactif de bas poids moléculaire pouvant provoquer, entre autres, des réactions d’hypersensibilité sévères. Bien que les micelles de PVP-b-PDLLA chargées de PTX aient démontré une meilleure tolérance comparée au Taxol®, leur potentiel de ciblage tumoral et leur efficacité thérapeutique étaient similaires à la forme commerciale à doses égales. Ceci était possiblement dû au fait que les micelles étaient rapidement déstabilisées et ne pouvaient retenir leur cargo suite à leur administration intraveineuse. Nous avons donc décidé de poursuivre les travaux avec un autre type de vecteur, soit des nanoparticules, qui possèdent une stabilité intrinsèque supérieure aux micelles. L’objectif principal de cette thèse de doctorat était donc de mettre au point des nanoparticules polymères pour l’administration parentérale d’agents anticancéreux faiblement solubles dans l’eau. Les nanoparticules devaient permettre d’encapsuler des agents anticancéreux hydrophobes et de les libérer de manière contrôlée sur plusieurs jours. De plus, elles devaient démontrer un temps de circulation plasmatique prolongée afin de favoriser l’accumulation passive du médicament encapsulé au niveau de la tumeur. La première partie du travail visait à employer pour la première fois le copolymère amphiphile PVP-b-PDLLA comme émulsifiant dans la préparation de nanoparticules polymères. Ainsi, une méthode de fabrication des nanoparticules par émulsion huile-dans-eau a été appliquée afin de produire des nanoparticules à base de PDLLA de taille inférieure à 250 nm. Grâce aux propriétés lyoprotectrices de la couronne de PVP présente à la surface des nanoparticules, celles-ci pouvaient retrouver leur distribution de taille initiale après lyophilisation et redispersion en milieu aqueux. Deux anticancéreux hydrophobes, soit le PTX et l’étoposide (ETO), ont été encapsulés dans les nanoparticules et libérés de ces dernières de façon contrôlée sur plusieurs jours in vitro. Une procédure de « salting-out » a été appliquée afin d’améliorer le taux d’incorporation de l’ETO initialement faible étant donnée sa solubilité aqueuse légèrement supérieure à celle du PTX. Le second volet des travaux visait à comparer le PVP comme polymère de surface des nanoparticules au PEG, le polymère le plus fréquemment employé à cette fin en vectorisation. Par le biais d’études d’adsorption de protéines, de capture par les macrophages et de biodistribution chez le rat, nous avons établi une corrélation in vitro/in vivo démontrant que le PVP n’était pas un agent de surface aussi efficace que le PEG. Ainsi, malgré la présence du PVP à la surface des nanoparticules de PDLLA, ces dernières étaient rapidement éliminées de la circulation sanguine suite à leur capture par le système des phagocytes mononucléés. Par conséquent, dans le troisième volet de cette thèse, le PEG a été retenu comme agent de surface, tandis que différents polymères biodégradables de la famille des polyesters, certains synthétiques (PDLLA et copolymères d’acide lactique/acide glycolique), d’autres de source naturelle (poly(hydroxyalkanoates)(PHAs)), ont été investiguées comme matériaux formant le cœur des nanoparticules. Il en est ressorti que les propriétés physicochimiques des polyesters avaient un impact majeur sur l’efficacité d’encapsulation du PTX et son profil de libération des nanoparticules in vitro. Contrairement aux PHAs, les polymères synthétiques ont démontré des taux d’incorporation élevés ainsi qu’une libération contrôlée de leur cargo. Des études de pharmacocinétique et de biodistribution ont démontré que les nanoparticules de PDLLA dotées d’une couronne de PEG conféraient un temps de circulation plasmatique prolongé au PTX et favorisaient son accumulation tumorale. Les nanoparticules polymères représentent donc une alternative intéressante au Taxol®. / Many highly potent anticancer drugs are characterized by poor aqueous solubility and can impart significant systemic toxicity. This toxicity can be attributed in part to the solubilisation of these anticancer agents with low molecular weight surfactants that are known to cause serious biological side effects on their own. Moreover, following their intravenous (IV) injection, the anticancer agents distribute throughout the body, causing deleterious effects in healthy organs and tissues. Colloidal polymeric drug carriers have been investigated as a means to circumvent these drawbacks. First, polymeric materials can be tailored to meet specific requirements in terms of biocompatibility, biodegradability and affinity for the cargo molecule. Second, associating a drug to a carrier system can drastically alter its distribution throughout the body, enhancing its deposition at the target site, e.g. the tumour, while sparing healthy tissues, thus minimizing systemic toxicity. Previous work in our group has led to the design of block copolymer micelles based on poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) (PVP-b-PDLLA) that were shown to solubilise hydrophobic anticancer agents such as paclitaxel (PTX). PTX is commercially available as Taxol®, a Cremophor EL (CrEL)-based formulation. CrEL is a low molecular weight surfactant that has been linked to severe side effects including life-threatening hypersensitivity reactions. Although PTX-loaded PVP-b-PDLLA micelles have demonstrated much improved tolerability compared to Taxol®, they did not increase PTX tumoral concentrations and exhibited anticancer efficacy similar to Taxol® at equivalent dosage. This was attributed to rapid destabilisation of the micelles and release of their cargo following IV administration. We chose to pursue our work with a colloidal drug carrier that exhibits greater stability compared to block copolymer micelles, i.e. polymeric nanoparticles. The main objective of this project was to develop polymeric nanoparticles for the parenteral delivery of hydrophobic anticancer drugs. The nanoparticles had to meet certain requirements such as be able to encapsulate hydrophobic anticancer drugs and release them in a controlled fashion over several days. Furthermore, the nanoparticles should confer prolonged plasma residence times to the encapsulated drug and favour its passive accumulation at its intended site of action, i.e. the tumour. The first part of this work focussed on applying PVP-b-PDLLA for the first time as polymeric emulsifier for the preparation of PDLLA nanoparticles with appropriate mean diameters (250 nm) using an oil-in-water emulsion method. Two hydrophobic anticancer drugs, PTX and etoposide (ETO), were successfully incorporated into the nanoparticles. A salting-out method was applied to enhance the loading efficiency of ETO, which was initially low given its slightly higher aqueous solubility compared to PTX. Both drugs were released in a controlled fashion from the PDLLA nanoparticles in vitro. Because of the lyoprotective effect of PVP, the polymer corona allowed for the particles to be easily redispersed in aqueous media following lyophilisation. The second part of the thesis aimed at evaluating whether the PVP coating could confer “stealth” properties to the PDLLA nanoparticles. Our study provided direct comparison between PVP and PEG, the most widely employed surface agent in drug delivery. In vitro protein adsorption and phagocytosis studies corroborated the in vivo findings, which showed that PVP-coated nanoparticles were rapidly cleared from circulation following their uptake by the mononuclear phagocyte system. Hence, our results indicated that PVP as coating materiel is not as efficient as PEG in conferring “stealth” properties to polymeric nanoparticles. Consequently, in the last section of this thesis, PEG was selected as coating agent while various biodegradable polymers were investigated as core-forming materials. Both synthetic (PDLLA and lactide/glycolide copolymers) and natural (polyhydroxyalkanoates (PHAs)) polyesters were tested. Our results demonstrated that the physicochemical properties of the polyesters significantly influenced the loading efficiency and release kinetics of PTX. While nanoparticles based on synthetic polyesters exhibited high encapsulation levels and controlled PTX release in vitro, PHA-based nanoparticles exhibited immediate unloading of their cargo. Pharmacokinetic and biodistribution studies in rodents revealed that encapsulating PTX in PEG-coated PDLLA-based nanoparticles led to enhanced plasma residence time and tumour deposition of the drug compared to Taxol®. Polymeric nanoparticles thus represent an appealing alternative to Taxol®.

La préparation de formulations à libération contrôlée est le domaine des sciences pharmaceutiques qui vise à modifier l’environnement immédiat des principes actifs pour en améliorer l’efficacité et l’innocuité. Cet objectif peut être atteint en modifiant la cinétique de circulation dans le sang ou la distribution dans l’organisme. Le but de ce projet de recherche était d’étudier le profil pharmacocinétique (PK) de différentes formulations liposomales. L’analyse PK, généralement employée pour représenter et prédire les concentrations plasmatiques des médicaments et de leurs métabolites, a été utilisée ici pour caractériser in vivo des formulations sensibles au pH servant à modifier la distribution intracellulaire de principes actifs ainsi que des liposomes destinés au traitement des intoxications médicamenteuses. Dans un premier temps, la PK d’un copolymère sensible au pH, à base de N-isopropylacrylamide (NIPAM) et d’acide méthacrylique (MAA) a été étudiée. Ce dernier, le p(NIPAM-co-MAA) est utilisé dans notre laboratoire pour la fabrication de liposomes sensibles au pH. L’étude de PK conduite sur les profils de concentrations sanguines de différents polymères a défini les caractéristiques influençant la circulation des macromolécules dans l’organisme. La taille des molécules, leur point de trouble ainsi que la présence d’un segment hydrophobe à l’extrémité des chaînes se sont avérés déterminants. Le seuil de filtration glomérulaire du polymère a été évalué à 32 000 g/mol. Finalement, l’analyse PK a permis de s’assurer que les complexes formés par la fixation du polymère à la surface des liposomes restaient stables dans le sang, après injection par voie intraveineuse. Ces données ont établi qu’il était possible de synthétiser un polymère pouvant être adéquatement éliminé par filtration rénale et que les liposomes sensibles au pH préparés avec celui-ci demeuraient intacts dans l’organisme. En second lieu, l’analyse PK a été utilisée dans le développement de liposomes possédant un gradient de pH transmembranaire pour le traitement des intoxications médicamenteuses. Une formulation a été développée et optimisée in vitro pour capturer un médicament modèle, le diltiazem (DTZ). La formulation liposomale s’est avérée 40 fois plus performante que les émulsions lipidiques utilisées en clinique. L’analyse PK des liposomes a permis de confirmer la stabilité de la formulation in vivo et d’analyser l’influence des liposomes sur la circulation plasmatique du DTZ et de son principal métabolite, le desacétyldiltiazem (DAD). Il a été démontré que les liposomes étaient capables de capturer et de séquestrer le principe actif dans la circulation sanguine lorsque celui-ci était administré, par la voie intraveineuse. L’injection des liposomes 2 minutes avant l’administration du DTZ augmentait significativement l’aire sous la courbe du DTZ et du DAD tout en diminuant leur clairance plasmatique et leur volume de distribution. L’effet de ces modifications PK sur l’activité pharmacologique du médicament a ensuite été évalué. Les liposomes ont diminué l’effet hypotenseur du principe actif administré en bolus ou en perfusion sur une période d’une heure. Au cours de ces travaux, l’analyse PK a servi à établir la preuve de concept que des liposomes possédant un gradient de pH transmembranaire pouvaient modifier la PK d’un médicament cardiovasculaire et en diminuer l’activité pharmacologique. Ces résultats serviront de base pour le développement de la formulation destinée au traitement des intoxications médicamenteuses. Ce travail souligne la pertinence d’utiliser l’analyse PK dans la mise au point de vecteurs pharmaceutiques destinés à des applications variées. À ce stade de développement, l’aspect prédictif de l’analyse n’a pas été exploité, mais le côté descriptif a permis de comparer adéquatement diverses formulations et de tirer des conclusions pertinentes quant à leur devenir dans l’organisme. / Drug delivery is the field of pharmaceutical sciences which focuses on altering the immediate environment of drug molecules to improve their efficacy and safety. Drug delivery systems can potentiate the effect of active principles or alleviate their side effects by modifying their circulation profiles and/or biodistribution. The objective of this research project was to investigate the role of pharmacokinetic (PK) analysis in the development of novel drug delivery systems. PK analysis is generally applied to describe and predict the blood concentration profiles of low molecular weight drugs and their metabolites. Nevertheless, it is herein used to characterize the circulation of 2 liposomal formulations: pH-sensitive liposomes designed to alter the intracellular distribution of drugs and liposomes with transmembrane pH gradient for drug detoxification. The first series of experiments were designed to study the circulation kinetics of a pH-sensitive polymer prepared with N-isopropylacrylamide (NIPAM) and methacrylic acid (MAA). The copolymer p(NIPAM-co-MAA) is used in our laboratory to prepare serum-stable, PEGylated, pH-sensitive liposomes. The circulation profiles of polymers with different characteristics were characterized. The parameters which impacted the fate of the macromolecules were the length of the polymer chain, its cloud point and the presence of a hydrophobic anchor at one extremity of the molecule. The glomerular filtration cut-off of the polymer was determined to be around 32,000 g/mol. PK analysis allowed to conclude that the complexes prepared by anchoring the polymer on the surface of the liposomes remained stable in the bloodstream. This data established that pH-sensitive vesicular formulations could be produced using a polymer which could be excreted through renal filtration. It also confirmed that the formulation remained intact in the bloodstream. The second part of this work involved the development of liposomes with a transmembrane pH gradient designed to treat cardiovascular drug intoxications. Liposomes were designed and optimized in vitro to capture a model cardiovascular drug, diltiazem (DTZ). In vitro, the liposome uptake capacity was 40-fold higher than the lipid emulsion used in the clinic. PK analysis was used to verify the stability of the formulation in vivo, and to assess the impact of the liposomes on the plasma concentration of DTZ and its principal active metabolite, deacetyl-diltiazem (DAD). It was shown that the vesicles were able to capture and sequester DTZ and DAD. Injection of liposomes 2 min prior to administration of DTZ significantly increased the area under the plasma-concentration vs. time curve of both DTZ and DAD, while lowering their clearance and volume of distribution. The impact of the changes in PK on the pharmacological effect of the drug was also investigated. Liposomes tempered the hypotensive effect of the drug when the latter was administered via an intravenous bolus or a 1-h perfusion. Throughout this work, PK analysis proved to be an efficient tool to study the ability of transmembrane pH gradient liposomes to alter the blood circulation profiles of a cardiovascular drug, and to reduce its pharmacological effect. This proof of concept establishes firm ground for the further development of this colloidal formulation to treat drug intoxications. This work pointed out the relevance of PK analysis for the development of multi-purpose, colloidal drug delivery systems. At this stage, the predictive nature of the analysis was not exploited, but its descriptive properties allowed objective comparison of the circulation profiles of distinct systems and pertinent conclusions concerning their fate in vivo.

Tissue engineering and regenerative medicine have emerged as viable approaches to repairing osteochondral tissue damage, especially with the implementation of biomaterials and mesenchymal stem cells (MSCs). Poly(vinyl alcohol) (PVA) is a synthetic and non-biodegradable polymer that has received attention as a tissue engineering scaffold and cartilage replacement due to its inherent viscoelasticity and biocompatibility. This work investigated the use of mechanical cues to trigger mechanotransduction pathways and thereby guide human MSCs towards a desired differentiation lineage. PVA scaffolds with a range of compressive moduli (1 - 600 kPa) were fabricated by varying molecular weight, solution concentration, and freeze-thaw cycles. Mass loss rates and changes in stiffness were not significantly different after 7 days of dynamic compression or static culture in standard MSC culture medium. Short-term dynamic loading of human MSC-seeded PVA scaffolds resulted in an increase in cell viability and collagen production for loaded versus static samples over 7 days of culture. Through a simple dynamic compressive loading sequence MSC viability and matrix protein production may increase on synthetic, bioinert PVA scaffolds. Lastly upstream processing of polymer fabrication and cell culture was conducted in preparation for studies on a custom designed dynamic compressive loading machine for cell-seeded scaffolds.